首页 | 本学科首页   官方微博 | 高级检索  
检索        

药品临床宣传资料中存在的问题与思考
引用本文:廖晓玲,刘红梅,王艾军,黄丽姜.药品临床宣传资料中存在的问题与思考[J].中国药房,2005,16(2):132-133.
作者姓名:廖晓玲  刘红梅  王艾军  黄丽姜
作者单位:解放军第421医院,广州市,510318
摘    要:目的 :探讨药品临床宣传资料中存在的问题及其解决办法。方法 :随机抽取本院药库35份药品的临床宣传资料 ,分别与其生产企业提供的药品说明书进行对照分析 ,着重比较其适应证和用法用量。结果 :有8份 (22 86 % )药品临床宣传资料与药品说明书内容不符 ,主要表现为扩大适应证、用法用量不一致。结论 :应从根本上提高企业和促销人员自身的科技含量和综合素质 ,药品监管部门应对药品上市后的营销行为给予一定的法律制约。

关 键 词:药品宣传资料  药品说明书  药品监管机制
文章编号:1001-0408(2005)02-0132-02
修稿时间:2004年5月9日

Problems in Publicity Materials of Drugs
LIAO Xiaoling,LIU Hongmei,WANG Aijun,HUANG Lijiang.Problems in Publicity Materials of Drugs[J].China Pharmacy,2005,16(2):132-133.
Authors:LIAO Xiaoling  LIU Hongmei  WANG Aijun  HUANG Lijiang
Abstract:OBJECTIVE:To investigate the problems in the publicity materials of drugs and to discuss the solutions to these problems.METHODS:35copies of publicity materials were randomly chosen from our hospital's pharmacy and were compared with the drug instructions provided by the same manufacturers.Indication,dosage and administration were the main items compared.RESULTS:Inconsistency was found in8out of35copies(22.86%),which was manifested in three aspects:widening of indications,increase in dosages,and inconsistency in administration.CONCLUSIONS:It is suggested that the technology of manufacturers and the comprehensive quality of salesmen should be improved basically.Furthermore,the suˉpervisory administration should establish the law to limit drug promotion sales.
Keywords:Publicity materials of drugs  Drug instructions  Drug supervisory administration
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号